Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Unichem Lab Gains 5%; BSE HEALTHCARE Index Down 0.4%
Tue, 22 Oct 10:26

Unichem Lab Gains 5%; BSE HEALTHCARE Index Down 0.4%Image source: alexsl/www.istockphoto.com

Unichem Lab share price has zoomed 5% and is presently trading at Rs 796.8.

Meanwhile, the BSE HEALTHCARE index is at 43,664.8 (down 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 1.3%) and CAPLIN POINT (up 1.1%).

Jubilant Pharmova (down 2.8%) and Pfizer (down 2.2%) are among the top losers today.

Over the last one year, Unichem Lab has moved up from Rs 421.8 to Rs 796.8, registering a gain of Rs 375.0 (up 88.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,328.3 to 43,664.8, registering a gain of 54.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 180.8%), SUVEN PHARMACEUTICALS (up 117.5%) and Glenmark Pharma (up 115.0%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,013.0 (down 0.2%).

The top losers among the BSE Sensex today are Tata Motors (down 1.9%) and Tata Steel (down 1.8%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,713.8 (down 0.3%). Tata Motors and Maruti Suzuki are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,877.0 to 81,013.0, registering a gain of 15,136.0 points (up 23.0%).

Unichem Lab Financial Update...

Unichem Lab net profit grew 1485.5% YoY to Rs 93 million for the quarter ended June 2024, compared to a loss of Rs 7 million a year ago. Net sales rose 5.5% to Rs 4,464 million during the period as against Rs 4,232 million in April-June 2023.

For the year ended March 2024, Unichem Lab reported 65.2% increase in net profit to Rs -705 million compared to net loss of Rs 2,022 million during FY23. Revenue of the company grew 26.9% to Rs 17,049 million during FY24.

The current Price to earnings ratio of Unichem Lab, based on rolling 12 month earnings, stands at -92.6.


Equitymaster requests your view! Post a comment on "Unichem Lab Gains 5%; BSE HEALTHCARE Index Down 0.4%". Click here!